The global breast lesion localization market size was USD 254 million in 2021 and it is anticipated to reach USD 390.6 million in 2031, growing at a rate of 4.4% from 2022-2031.
Global breast lesion localization report from Global Insight Services is the single authoritative source of intelligence on breast lesion localization market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Breast lesion localization is a medical device used in the detection of malignant and nonmalignant tumors. It is used in the preoperative marketing of nonpalatable breast lesions. There are different types f breast lesion localization devices developed using different techniques: radiations, wires, radar, and electromagnetic. Breast lesion localization methods are used to detect the abnormalities in terms of a lump or tumor in the breasts. There are various types of breast lesion localization methods used across the globe to detect a lump or tumor in the breasts. However, the rapid increase in the number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for the growth of the breast lesion localization market.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10248
Major Players of the Global Breast Lesion Localization Market
The global breast lesion localization market report includes players such as Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US), Laurane Medical LLC (France), Endomagnetics Ltd. (UK), Intramedical Imaging, LLC (US), Isoaid (US), Surgiceye GmbH (Germany), Ranfac Corp. (US), Mermaid Medical Group (Denmark), Izi Medical Products, LLC (US), Matek Medikal (Turkey), Tsunami Medical Srl (Italy), BPB Medica (Italy), Sirius Medical Systems B.V. (Netherlands), Molli Surgical Inc. (Canada), Sterylab S.R.L. (Italy), CP Medical (Georgia), MDL SRL (Italy), Biomedical Srl (Italy), Elucent Medical (US), Vigeo srl (Italy), and Medax Medical Devices (Italy).
Global Breast Lesion Localization Market Segmentation
The report analyses the breast lesion localization market based on type, usage, and region.
Global Breast Lesion Localization Market by Type
On the basis of type, it is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization methods. The radioisotope localization segment is also sub-segmented into radio-guided occult lesion localization and radioactive seed localization. The wire localization segment is likely to dominate the market during the forecast period. The increasing incidence of breast cancer combined with the increasing adoption of expansion strategies by manufacturers of lesion localization products, product launches, and increasing healthcare expenditure are a major factor driving the global breast lesion localization market.
Global Breast Lesion Localization Market by Usage
On the basis of usage, it is segmented into breast biopsy and breast conservation (lumpectomy). The breast biopsy segment is likely to dominate the market during the forecast period. The key factors such as increasing consumption of alcohol and a sedentary lifestyle causing obesity are boosting the growth of the market.
Purchase your copy now: https://www.globalinsightservices.com/inquiry-before-buying/GIS10248
Market Trends and Drivers
The major factor boosting the growth of the market is the increasing incidence of breast cancer. Breast cancer is among the most common diseases affecting women in developed and developing countries. As per the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women globally. Worldwide, there has been significant growth in the number of breast cancer cases. This can majorly be attributed to changing lifestyles, the increasing use of oral contraceptives, and the rising number of women undergoing cosmetic surgeries, such as breast enhancement.
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700